Literature DB >> 18078995

Regulation of NFAT by poly(ADP-ribose) polymerase activity in T cells.

Rut Valdor1, Valérie Schreiber, Luis Saenz, Teresa Martínez, Alba Muñoz-Suano, Margarita Dominguez-Villar, Pablo Ramírez, Pascual Parrilla, Enrique Aguado, Francisco García-Cózar, José Yélamos.   

Abstract

The nuclear factor of activated T cells (NFAT) family of transcription factors is pivotal for T lymphocyte functionality. All relevant NFAT activation events upon T cells stimulation such as nuclear translocation, DNA binding, and transcriptional activity have been shown to be dictated by its phosphorylation state. Here, we provide evidence for a novel post-translational modification that regulates NFAT. Indeed, NFATc1 and NFATc2 are poly(ADP-ribosyl)ated by poly-ADP-ribose polymerase-1 (PARP-1). Moreover, we have also found a physical interaction between PARP-1 and both NFATc1 and NFATc2. Interestingly, PARP is activated during T cell stimulation in the absence of DNA damage, leading to ADP-ribose polymers formation and transfer to nuclear acceptor proteins. Our data suggest that poly(ADP-ribosyl)ation modulates the activation of NFAT in T cells, as PARP inhibition causes an increase in NFAT-dependent transactivation and a delay in NFAT nuclear export. Poly(ADP-ribosyl)ation will expedited NFAT export from the nucleus directly or by priming/facilitating NFAT phosphorylation. Altogether, these data point to PARP-1 and poly(ADP-ribosyl)ation as a novel regulatory mechanism of NFAT at nuclear level, suggesting a potential use of PARP as a new therapeutic target in the modulation of NFAT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18078995     DOI: 10.1016/j.molimm.2007.10.044

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  37 in total

Review 1.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

Review 2.  Metabolic checkpoints in activated T cells.

Authors:  Ruoning Wang; Douglas R Green
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

Review 3.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

4.  Coordinated signals from PARP-1 and PARP-2 are required to establish a proper T cell immune response to breast tumors in mice.

Authors:  Lucia Moreno-Lama; Miguel A Galindo-Campos; Carlos Martínez; Laura Comerma; Ivonne Vazquez; María Vernet-Tomas; Coral Ampurdanés; Nura Lutfi; Juan Martin-Caballero; Françoise Dantzer; Miguel Quintela-Fandino; Syed O Ali; Jaime Jimeno; José Yélamos
Journal:  Oncogene       Date:  2020-01-30       Impact factor: 9.867

5.  Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.

Authors:  Christian H Gabriel; Fridolin Gross; Martin Karl; Heike Stephanowitz; Anna Floriane Hennig; Melanie Weber; Stefanie Gryzik; Ivo Bachmann; Katharina Hecklau; Jürgen Wienands; Johannes Schuchhardt; Hanspeter Herzel; Andreas Radbruch; Eberhard Krause; Ria Baumgrass
Journal:  J Biol Chem       Date:  2016-09-16       Impact factor: 5.157

Review 6.  Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.

Authors:  Joanna B Strosznajder; Grzegorz A Czapski; Agata Adamczyk; Robert P Strosznajder
Journal:  Mol Neurobiol       Date:  2012-03-20       Impact factor: 5.590

7.  Poly(ADP-ribosyl)ation of FOXP3 Protein Mediated by PARP-1 Protein Regulates the Function of Regulatory T Cells.

Authors:  Xuerui Luo; Jia Nie; Shuaiwei Wang; Zuojia Chen; WanJun Chen; Dan Li; Hui Hu; Bin Li
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

Review 8.  Beyond DNA repair, the immunological role of PARP-1 and its siblings.

Authors:  Maria Manuela Rosado; Elisabetta Bennici; Flavia Novelli; Claudio Pioli
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

9.  PARP-1 deficiency increases the severity of disease in a mouse model of multiple sclerosis.

Authors:  Vimal Selvaraj; Mangala M Soundarapandian; Olga Chechneva; Ambrose J Williams; Maxim K Sidorov; Athena M Soulika; David E Pleasure; Wenbin Deng
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

Review 10.  Enhancing tumor-targeting monoclonal antibodies therapy by PARP inhibitors.

Authors:  José Yélamos; Miguel Galindo; Judith Navarro; Joan Albanell; Ana Rovira; Federico Rojo; Javier Oliver
Journal:  Oncoimmunology       Date:  2015-07-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.